Sale!

VPS13A Gene Choreoacanthocytosis Genetic Test

Original price was: $700.Current price is: $500.

-29%

The VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the VPS13A gene responsible for chorea-acanthocytosis, a rare neurological disorder. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide precise genetic analysis for individuals experiencing movement disorders, cognitive changes, and neuromuscular symptoms. The test helps confirm diagnosis, guide treatment decisions, and provide crucial information for family planning. With results available in 3-4 weeks and requiring only a simple blood sample, this test offers invaluable insights for patients and their families. The discounted price is $500 USD, providing affordable access to advanced genetic testing.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with chorea-acanthocytosis. This rare, inherited neurodegenerative disorder affects multiple body systems and typically manifests in early adulthood. Our advanced testing methodology provides patients and healthcare providers with definitive genetic information crucial for accurate diagnosis and personalized treatment planning.

What This Test Measures and Detects

This specialized genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the VPS13A gene for pathogenic variants. The test specifically identifies:

  • Point mutations, insertions, and deletions in the VPS13A gene
  • Autosomal recessive inheritance patterns
  • Genetic markers associated with chorea-acanthocytosis development
  • Risk assessment for family members through genetic counseling

Who Should Consider This Test

Individuals experiencing the following symptoms should consider the VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test:

  • Involuntary movements (chorea) affecting face, limbs, and trunk
  • Progressive muscle weakness and atrophy
  • Cognitive changes including memory impairment and executive dysfunction
  • Seizures or epilepsy-like episodes
  • Behavioral and personality changes
  • Family history of similar neurological symptoms
  • Unexplained progressive neurological deterioration

Key Benefits of Genetic Testing

Undergoing the VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test provides numerous advantages:

  • Definitive Diagnosis: Confirm or rule out chorea-acanthocytosis with genetic certainty
  • Early Intervention: Enable timely treatment and symptom management
  • Family Planning: Provide crucial information for reproductive decisions
  • Personalized Care: Guide targeted therapeutic approaches
  • Genetic Counseling: Support for patients and family members
  • Research Contribution: Advance understanding of rare neurological disorders

Understanding Your Test Results

Our comprehensive results interpretation includes:

  • Positive Result: Indicates presence of VPS13A gene mutations confirming chorea-acanthocytosis diagnosis
  • Negative Result: Suggests absence of detectable mutations, though clinical evaluation remains essential
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • Carrier Status: Identifies individuals with single mutation copies who may pass the condition to offspring

All results are accompanied by detailed explanations and genetic counseling recommendations to ensure complete understanding and appropriate next steps.

Test Pricing and Details

Test Feature Details
Test Name VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Methodology Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure optimal testing outcomes, we require:

  • Complete clinical history of the patient
  • Genetic counseling session to create detailed family pedigree
  • Documentation of affected family members
  • Neurological evaluation records

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, and Philadelphia. Our network of certified genetic counselors and neurological specialists ensures comprehensive care regardless of your location.

Take Control of Your Neurological Health

Don’t let uncertainty about neurological symptoms affect your quality of life. The VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test provides the clarity needed for informed medical decisions and personalized treatment strategies. Our team of genetic specialists and neurologists is ready to support you through every step of the testing process.

Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Take the first step toward definitive diagnosis and personalized neurological care.